Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV Associated Solid Tumors With Expansion Cohort in HIV Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin Lymphoma

NCT02408861 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02408861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02408861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV Associated Solid Tumors With Expansion Cohort in HIV Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin Lymphoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Terminated
Start date
October 21, 2015
Completion date
August 31, 2024
Enrollment
79 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid neoplasm, anal carcinoma, hiv infection, hiv-associated cancers, kaposi sarcoma, lung carcinoma, metastatic malignant solid neoplasm, recurrent classic hodgkin lymphoma, refractory classic hodgkin lymphoma, unresectable solid neoplasm